Thrivent Financial For Lutherans Vyne Therapeutics Inc. Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$0.37 - $0.71 $3,936 - $7,554
-10,640 Reduced 16.19%
55,064 $21,000
Q4 2021

Feb 16, 2022
SELL
$0.91 - $1.5 $5,720 - $9,429
-6,286 Reduced 8.73%
65,704 $67,000
Q3 2021

Nov 15, 2021
BUY
$1.39 - $3.47 $16,827 - $42,007
12,106 Added 20.22%
71,990 $101,000
Q2 2021

Aug 19, 2021
BUY
$3.24 - $6.92 $194,024 - $414,397
59,884 New
59,884 $211,000

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $179M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email